Log In
BCIQ
Print this Print this
 

IC200214, ITI-002

  Manage Alerts
Collapse Summary General Information
Company Intra-Cellular Therapies Inc.
DescriptionOral phosphodiesterase-1 (PDE-1) inhibitor
Molecular Target Phosphodiesterase-1 (PDE-1)
Mechanism of ActionPhosphodiesterase-1 (PDE-1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$750.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/02/2011

Undisclosed

Undisclosed

$750.0M

Get a free BioCentury trial today